rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2007-10-2
|
pubmed:abstractText |
Eleven postmenopausal women with Parkinson disease and levodopa-induced peak-dose dyskinesias underwent a double-blind, placebo-controlled, crossover study. The active treatment consisted of estrogen replacement therapy for 12 weeks, followed by medroxyprogesterone acetate for 2 weeks. Estrogen replacement therapy-medroxyprogesterone acetate administration significantly improved peak-dose dyskinesia without worsening motor disability, thus suggesting a possible benefit on dyskinesias in postmenopausal women with Parkinson disease.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0362-5664
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
276-80
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:17909305-Aged,
pubmed-meshheading:17909305-Akathisia, Drug-Induced,
pubmed-meshheading:17909305-Antineoplastic Agents, Hormonal,
pubmed-meshheading:17909305-Antiparkinson Agents,
pubmed-meshheading:17909305-Cross-Over Studies,
pubmed-meshheading:17909305-Double-Blind Method,
pubmed-meshheading:17909305-Estrogens,
pubmed-meshheading:17909305-Female,
pubmed-meshheading:17909305-Humans,
pubmed-meshheading:17909305-Levodopa,
pubmed-meshheading:17909305-Medroxyprogesterone Acetate,
pubmed-meshheading:17909305-Middle Aged,
pubmed-meshheading:17909305-Parkinson Disease,
pubmed-meshheading:17909305-Postmenopause,
pubmed-meshheading:17909305-Severity of Illness Index,
pubmed-meshheading:17909305-Treatment Outcome
|
pubmed:articleTitle |
Hormonal replacement therapy in women with Parkinson disease and levodopa-induced dyskinesia: a crossover trial.
|
pubmed:affiliation |
Department of Neurosciences, University of Catania, Via Santa Sofia no. 78, 95123 Catania, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|